Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Chemours (CC) Operating Expenses (2016 - 2025)

Chemours has reported Operating Expenses over the past 12 years, most recently at $161.0 million for Q4 2025.

  • Quarterly results put Operating Expenses at $161.0 million for Q4 2025, down 21.08% from a year ago — trailing twelve months through Dec 2025 was $966.0 million (up 17.38% YoY), and the annual figure for FY2025 was $966.0 million, up 17.38%.
  • Operating Expenses for Q4 2025 was $161.0 million at Chemours, up from $152.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for CC hit a ceiling of $806.0 million in Q2 2023 and a floor of $152.0 million in Q3 2025.
  • Median Operating Expenses over the past 5 years was $186.5 million (2021), compared with a mean of $244.4 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 187.86% in 2023 and later crashed 77.3% in 2024.
  • Chemours' Operating Expenses stood at $190.0 million in 2021, then rose by 11.05% to $211.0 million in 2022, then rose by 21.8% to $257.0 million in 2023, then dropped by 20.62% to $204.0 million in 2024, then fell by 21.08% to $161.0 million in 2025.
  • The last three reported values for Operating Expenses were $161.0 million (Q4 2025), $152.0 million (Q3 2025), and $470.0 million (Q2 2025) per Business Quant data.